Lactation, oxytocin and maternal cardiovascular function later in life
哺乳期、催产素和母亲晚年心血管功能
基本信息
- 批准号:10646388
- 负责人:
- 金额:$ 45.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:ADP-ribosyl CyclaseAdipose tissueAffectAgeBehaviorBirthBlood PressureBlood VesselsBody WeightBottle feedingBrainBrain regionBreast FeedingCardiacCardiometabolic DiseaseCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCause of DeathCerebellumChild HealthChronic DiseaseDevelopmentDiastolic blood pressureDiscipline of NursingEFRACEchocardiographyElderlyEnterobacteria phage P1 Cre recombinaseEpigenetic ProcessEventExposure toFeedbackFoundationsFunctional disorderFutureGenderGene ExpressionGoalsHealthHeartHigh Fat DietHourHumanHypertensionHypothalamic structureIn VitroInfantInterventionKnockout MiceLactationLifeLinkLong-Term EffectsLow-Density LipoproteinsLoxP-flanked alleleMaternal HealthMeasuresMediatingMessenger RNAMetabolicMetabolic syndromeMilkMilk EjectionModelingMothersMusNeuronsNeuropeptidesNewborn InfantNipplesObesityObservational StudyOperative Surgical ProceduresOrganOutcomeOutputOxytocinOxytocin ReceptorPatternPeripheralPhenotypePhysiologicalPlasmaPlayPostpartum PeriodPregnancyProceduresProductionProsencephalonReflex actionRegulationReportingRisk MarkerRoleSocial BehaviorStroke VolumeSystemTestingTherapeuticTimeTranslatingUterine ContractionVisceralWomanWomen&aposs Healthantagonistblood pressure reductioncardioprotectionconditional knockoutdesignfasting glucoseheart functionimprovedin vivolactation periodmagnocellularmenmicrographynoveloffspringparaventricular nucleusplacebo grouppost pregnancypregnantpreventpupsocialsucklingsupraoptic nucleus
项目摘要
1 ABSTRACT
2 Cardiovascular diseases (CVD) are the leading cause of death in women in the US. Women differ from men in
3 rates and timing of CVD and show a stronger association between CVD and metabolic syndrome. This
4 difference suggests that gender-specific factors may moderate the underlying pathophysiology of CVD. We
5 propose that lactation could be one such women-specific factor. Multiple observational studies have linked
6 breastfeeding with reduced maternal cardiometabolic disease later in life; however, the underlying mechanisms
7 for the beneficial effect of lactation remain unknown. Our central hypothesis is that high levels of oxytocin
8 produced during lactation protect breastfeeding mothers against cardiovascular diseases later in life.
9 We were the first to report significantly lower systolic and diastolic blood pressure; less adipose tissue; better
10 cardiac ejection fraction, output, and diastolic function; and lower concentrations of circulating cardiovascular
11 risk markers in mice that lactated compared to mice that did not lactate. Oxytocin (OXT) is a neuropeptide that
12 triggers uterine contractions, the milk let-down reflex during lactation, and plays a central role in maternal
13 behavior and social affiliation. OXT in physiological situations, such as pregnancy and lactation, induces its
14 own synthesis and release. In our model, we found significantly increased circulating OXT levels and mRNA
15 expression in mice that lactated. The objective of this study is to further define the mechanisms affecting
16 maternal cardiovascular and metabolic outcomes after lactation-induced OXT production. We will test 3
17 hypotheses: 1) OXT-stimulating events during lactation – suckling and maternal-pup interaction – are required
18 for dams to develop maternal cardioprotective phenotype later in life; 2) that higher levels of OXT in
19 postpartum lactated mice is a result from activation of central OXT-OXTR system; 3) administration of
20 exogenous OXT to nonlactating mice in the immediate post-delivery period will rescue the cardioprotective
21 phenotype with or without pre-existing chronic disease. Aim 1 is designed to mimic the bottle-feeding situation
22 in non-breastfeeding women; we will use mice with their nipples surgically removed. In Aim 2 we will use
23 conditional knockout mice (flox-Cre recombinase system) that are Oxtr deficient in the brain. In Aim 3 the
24 hypothesis will be tested in obesity-hypertension model. Longitudinal in vivo experimental procedures will
25 include measuring fasting glucose and blood pressure, and assessing cardiac function with echocardiogram
26 and adipose tissue using micro-computed micrography. In vitro, we will utilize organ explant and vascular
27 reactivity studies. In summary, our proposal will define the mechanisms by which lactation affects maternal
28 health later in life and quantify the causal effect of breastfeeding on maternal cardiovascular and metabolic
29 health. The results of our study may lead to further mechanistic explorations of the role of lactation in maternal
30 health, which could be directly translated into interventions to prevent CVD in women.
1篇摘要
2心血管疾病(CVD)是美国女性死亡的主要原因。女性与男性的不同之处在于
3心血管疾病的发病率和发病时间,并显示心血管疾病和代谢综合征之间有更强的相关性。这
4差异表明,性别特异性因素可能会缓和CVD的潜在病理生理学。我们
5提出哺乳可能是一个这样的妇女特有的因素。多项观察性研究表明,
6母乳喂养减少了母亲以后的心脏代谢疾病;然而,
7对哺乳的有益影响仍然未知。我们的核心假设是高水平的催产素
8在哺乳期产生的保护哺乳期母亲在以后的生活中免受心血管疾病。
我们是第一个报告收缩压和舒张压显著降低的人;脂肪组织更少;
10心脏射血分数、输出量和舒张功能;以及循环心血管
11个风险标志物的小鼠相比,乳酸小鼠没有乳酸。催产素(OXT)是一种神经肽,
12触发子宫收缩,即哺乳期间的乳汁分泌反射,并在母体发育中发挥核心作用。
13行为和社会关系。生理情况下的OXT,如妊娠和哺乳,诱导其
14自己的合成和释放。在我们的模型中,我们发现循环OXT水平和mRNA水平显著增加,
15的表达。本研究的目的是进一步确定影响
16例哺乳诱导OXT产生后的母体心血管和代谢结局。我们将测试3
17个假设:1)需要哺乳期间的OXT刺激事件-哺乳和母鼠-幼崽相互作用
18的母体在以后的生活中发展出母体心脏保护表型; 2)
19只产后泌乳小鼠是中枢OXT-OXTR系统激活的结果;
在分娩后立即给予非哺乳期小鼠20个外源性OXT将挽救心脏保护性
21表型有或没有预先存在的慢性疾病。目标1是为了模仿奶瓶喂养的情况
22在非母乳喂养的女性;我们将使用手术切除乳头的小鼠。在目标2中,我们将使用
23只条件性基因敲除小鼠(EST-Cre重组酶系统),其在脑中是Oxtr缺陷的。在Aim 3中,
将在肥胖-高血压模型中检验24个假设。纵向体内实验程序将
25包括测量空腹血糖和血压,以及用超声心动图评估心脏功能
26和脂肪组织使用微计算机显微照相术。在体外,我们将利用器官外植体和血管
27项反应性研究。总之,我们的建议将确定哺乳影响产妇的机制,
28健康以后的生活和量化的因果影响母乳喂养对产妇心血管和代谢
29健康我们的研究结果可能会导致进一步的机制探讨哺乳的作用,在产妇
30健康,这可以直接转化为干预措施,以预防妇女心血管疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Egle Bytautiene Prewit其他文献
Egle Bytautiene Prewit的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Egle Bytautiene Prewit', 18)}}的其他基金
Lactation, Oxytocin and Maternal Cardiovascular Function.
哺乳期、催产素和母亲心血管功能。
- 批准号:
10774048 - 财政年份:2020
- 资助金额:
$ 45.35万 - 项目类别:
Lactation, oxytocin and maternal cardiovascular function later in life
哺乳期、催产素和母亲晚年心血管功能
- 批准号:
10207765 - 财政年份:2020
- 资助金额:
$ 45.35万 - 项目类别:
Lactation, oxytocin and maternal cardiovascular function later in life
哺乳期、催产素和母亲晚年心血管功能
- 批准号:
10455709 - 财政年份:2020
- 资助金额:
$ 45.35万 - 项目类别:
Investigation into statins as prevention and treatment of inflammation in pregnancy
他汀类药物预防和治疗妊娠期炎症的研究
- 批准号:
9975203 - 财政年份:2019
- 资助金额:
$ 45.35万 - 项目类别:
Long Term Implications of Preeclampsia: Role of Obesity vs sFlt-1 Overexpression
先兆子痫的长期影响:肥胖与 sFlt-1 过度表达的作用
- 批准号:
7689212 - 财政年份:2008
- 资助金额:
$ 45.35万 - 项目类别:
Long Term Implications of Preeclampsia: Role of Obesity vs sFlt-1 Overexpression
先兆子痫的长期影响:肥胖与 sFlt-1 过度表达的作用
- 批准号:
7813371 - 财政年份:2008
- 资助金额:
$ 45.35万 - 项目类别:
相似海外基金
Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
- 批准号:
MR/Y013891/1 - 财政年份:2024
- 资助金额:
$ 45.35万 - 项目类别:
Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
- 批准号:
BB/Y006542/1 - 财政年份:2024
- 资助金额:
$ 45.35万 - 项目类别:
Research Grant
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 45.35万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
- 批准号:
23K08293 - 财政年份:2023
- 资助金额:
$ 45.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
- 批准号:
479570 - 财政年份:2023
- 资助金额:
$ 45.35万 - 项目类别:
Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
- 批准号:
488898 - 财政年份:2023
- 资助金额:
$ 45.35万 - 项目类别:
Operating Grants
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
- 批准号:
23K19922 - 财政年份:2023
- 资助金额:
$ 45.35万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
A mechanism of lipid accumulation in brown adipose tissue
棕色脂肪组织中脂质积累的机制
- 批准号:
10605981 - 财政年份:2023
- 资助金额:
$ 45.35万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 45.35万 - 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
- 批准号:
10604611 - 财政年份:2023
- 资助金额:
$ 45.35万 - 项目类别: